StreetAlpha.app
Home › Stocks › PAVM

PAVmed Inc. (PAVM)

$1.14
▼ −5.42%
LAST CLOSE · NOV 20

PAVmed develops medical devices, diagnostics and digital health tools, including the EsoGuard test for esophageal precancer screening. It last closed at $1.14 on Nov 20, down 5.42% on the day. The next earnings report for PAVM is expected around Mon, Mar 29, 2027. For the quarter ended Sep 2026, PAVM reported EPS of -$1.77 on revenue of $41,000, with revenue up 720.0% from a year ago. Over its last 8 reports the stock moved an average of 9.2% the session after earnings.

AI Auto Pilots
Is PAVM in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold PAVM.

Key Stats

Last 12 months
Results
Revenue
$148K
+410.3% vs a year ago
Net income
−$18.4M
−693.3% vs a year ago
EPS (diluted)
−$7.37
−108.0% vs a year ago
Free cash flow
−$4.5M
−3024.3% margin
Valuation
Market cap
$9.1M
8.0M shares
P/E
–
No P/E while losing money
Price to sales
61.3
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$3.6M
At Sep 30
Shareholder equity
$27.5M
Shares outstanding
8.0M
At Nov 12
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $500K$500KFY2021FY2022: $377K$377KFY2022FY2023: $2.5M$2.5MFY2023FY2024: $3.0M$3.0MFY2024FY2025: $71K$71KFY2025

From PAVM's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 16). Last 12 months adds up the four latest quarters.

Next report
Mar 29
Estimated date · Time not announced
Reported EPS
-$1.77
Quarter ended Sep 2026
Year ago EPS
-$8.81
Same quarter last year
Revenue
$41,000
+720.0% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $95.85Dec '24Mar 2025: $38.26Mar '25Jun 2025: -$22.08Jun '25Sep 2025: -$8.81Sep '25Dec 2025: -$2.37Dec '25Mar 2026: -$4.42Mar '26Jun 2026: -$0.87Jun '26Sep 2026: -$1.77Sep '26Latest -$1.77
Revenue by quarter
Dec 2024: $10,000Dec '24Mar 2025: $8,000Mar '25Jun 2025: $6,000Jun '25Sep 2025: $5,000Sep '25Dec 2025: $52,000Dec '25Mar 2026: $22,000Mar '26Jun 2026: $33,000Jun '26Sep 2026: $41,000Sep '26Latest $41,000
How PAVM moved after its last 8 reports
Average move the session after a report ±9.2%
Nov 13, 2026Time not announced+21.7%
Aug 14, 2026Time not announced+9.7%
May 15, 2026Time not announced+1.2%
Mar 30, 2026Time not announced+13.0%
Nov 13, 2025Time not announced−8.5%
Aug 14, 2025Time not announced−0.8%
May 15, 2025Time not announced−13.7%
Mar 25, 2025Time not announced−5.1%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on PAVMStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on PAVM
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on PAVM

Technical Analysis

PAVM · as of the Nov 20 close · updated each morning
Downtrend, oversold

The stock is 48% below its 20 day and 124% below its 50 day average. It is 430% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 28), oversold. The nearest support is the 52 week low at $1.10, and the nearest resistance the Pivot at $1.18.

Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 24.6%/day
Key levels
$28.4452 week high+2394.7%
$6.01200 day average+427.2%
$3.84100 day average+236.8%
$2.5550 day average+123.7%
$2.29Swing high (Nov 16)+100.9%
$1.6820 day average+47.4%
$1.25Pivot R1+9.6%
$1.18Pivot+3.5%
$1.14Last close
$1.1052 week low−3.5%
$1.06Pivot S1−7.0%
Indicators
RSI (14)27.79Oversold below 30Oversold
MACD-0.36Above its signal lineBullish
Stochastic6.3Near the bottom of its rangeOversold
ADX (14)48.4Strong downtrend
Williams %R-97.1Oversold below −80, overbought above −20Oversold
CCI (20)-137.6Oversold below −100, overbought above 100Oversold
Rate of change−27.7%Change over 10 sessionsBearish
ATR (14)$0.28Typical daily range, 24.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for PAVM

What happened before

See how PAVM did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow PAVM usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How PAVM has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2016.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for PAVMHow many large options trades hit PAVM, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

PAVM Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ●8 buying vs 7 selling
  • ●Held by funds +0.4 pts
  • ▲Funds holding +3
  • ▲Superinvestors: 1 added, 0 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding2421+14.3%
In funds' top 1000–
Held by funds12.1%11.7%+0.4 pts
New / increased4 / 46 / 6−33.3%
Reduced / sold out4 / 33 / 5−12.5%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See PAVM institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PAVM is in one of them and how their past PAVM trades turned out.

PAVM in the AI portfolios
Loading…

PAVM News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered PAVM in an article yet. Here's the latest on the wider market.

PAVM in the news

About PAVmed

PAVmed is a New York based company that works in medical devices, diagnostics and digital health. Its main product is the EsoGuard test, a DNA test run on cells collected with the EsoCheck device, which is offered to doctors, health systems, employers and patients to screen people with chronic acid reflux for esophageal precancer. Its Veris Health unit provides digital tools for cancer patients during and after treatment. The company is also developing PortIO, an implantable vascular access device.

Headquarters
New York, NY